logo

ALPHARMA I(NYSE:ALO)
Alpharma Inc is a growing specialty pharmaceutical company with expanding global leadership positions in products for humans and animals. They are among the world''s leading producers of several important pharmaceutical-grade bulk antibiotics and are internationally recognized as a leading provider of pharmaceutical products for poultry, swine, cattle, and vaccines for farmed-fish worldwide. Alpharma is the #5 manufacturer of generic pharmaceutical products in the U.S., offering solid, liquid and topical pharmaceuticals.
# Employees: 2000
Address: 440 U.S. Highway 22 East,Bridgewater,NJ,USA
Phone: 908 566-3800
Fax: 908 566-4137
Website: www.alpharma.com
Email: investorrelations@alpharma.com
Sector: Medical
Industry: MED-GENERIC DRG
Executive Officers
Robert F. Wrobel (Exec. V.P.; Chief Legal Off.)
Peter G. Tombros (Chmn.; Dir.)
Dean J. Mitchell (Presi.; C.E.O.; Dir.)
Stefan Aigner (Exec. V.P.; Corp. & Business Develop.)
Richard J. Cella (Exec. V.P.; Chief Info. Off.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2008
Next Earnings Date(Expected): 2/24/2009
Mean EPS (Next Qtr): $0.23
Mean EPS (Year): $0.34
Mean Estimate(Long Term): $24.60
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 3
Shares Performance
Period ALO Compare to S&P
YTD -0.01 % 208.84 %
4 Weeks -0.01 % -0.01 %
12 Weeks -0.01 % -0.01 %
Shares Information
Analyst Coverage: Y
Avg Volume: 740655
Shares Outstanding: 41M
Market Cap: ($0.01)M
52 Week High: $37.75
52 Week Low: $18.00
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 4/30/1991 ALO split by factor of 1.500
Earnings Performance
EPS Growth in Last Quarter: 600.00 %
EPS Growth in Last Year: -70.59 %
Sales Growth in Last Quarter: 5.27 %
Sales Growth in Last Quarter: -0.06 %
Financials
Qtr Book Value: ($0.01)
Cash Flow/Share: ($0.01)
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia